Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab

Journal of Neuro-Ophthalmology

Volumn 29, Issue 2, 2009, Pages 160-161

  Hosseini, Hamid ^a   Razeghinejad, Mohammad Reza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; ISCHEMIC OPTIC NEUROPATHY; LETTER; NONARTERITIC ISCHEMIC OPTIC NEUROPATHY; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT; CHEMICALLY INDUCED DISORDER; EYE DISEASE; FLUORESCENCE ANGIOGRAPHY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METHODOLOGY; RISK FACTOR;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; EYE DISEASES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS, INTRAVENTRICULAR; OPTIC NEUROPATHY, ISCHEMIC; RISK FACTORS;

EID: 67651219405     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e3181a58fd1     Document Type: Letter

References (8)

1. Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the Internet to assess drug safety worldwide. Br J Ophthalmol 2006;90:1344-9.
2. Hayreh SS. Anterior ischemic optic neuropathy. VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis. Ophthalmology 1987;94:1488-502.
3. Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 2001;20:595-624.
4. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2003;23:157-63.
5. Ameri H, Chader GJ, Kim JG, et al. The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci 2007;48:5708-15.
6. Tomsak RL, Remler BF. Anterior ischemic optic neuropathy and increased intraocular pressure. J Clin Neuroophthalmol 1989;9: 116-8.
7. Kim JE, Mantravadi AV, Hur EY, et al. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008;146: 930-4.
8. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134: 317-28.